news
-
DOSIsoft unveils new ThinkQA 3.0 at ESTRO 2026: Unified PSQA Platform for Offline and Online Adaptive RadioTherapy
- May 6, 2026
Cachan, France | May 6, 2026 DOSIsoft, leading provider of dosimetry software solutions for radiation oncology and nuclear medicine, announces today it will showcase its new ThinkQA 3.0 – Unified PSQA Platform during the annual meeting of the European Society for Radiotherapy and Oncology (ESTRO), taking place on May 15 -19, 2026 in Stockholm, Sweden.
-
ASTRO Annual Meeting 2026
- April 13, 2026
68th Annual Meeting of American Society for Radiation Oncology (ASTRO)
September 26-30, 2026
Boston, MA, USA
Patient QA showcase on Elekta booth #1624 -
Joint AAPM & COMP Meeting 2026
- April 13, 2026
Joint AAPM & COMP Meeting
July 19-22, 2026
Vancouver, BC, USA
Patient QA showcase on Elekta booth #1131 -
SNMMI Annual Meeting 2026
- April 9, 2026
The SNMMI (Society of Nuclear Medicine and Molecular Imaging) Annual Meeting
May 30 – June 2, 2026
Los Angeles, CA, USA
Booth #1358 -
ESTRO Annual Congress 2026
- March 25, 2026
European SocieTy for Radiotherapy & Oncology (ESTRO) Annual Meeting
May 15-19, 2026
Stockholm, Sweden
Booth #C16:51 -
DGN Congress 2026
- March 23, 2026
4th Nuklearmedizin DGN-Jahrestagung
April 22-25, 2026
Münster, Germany
Oncosia Booth A12 -
Turkish Society for Nuclear Medicine Annual Congress 2026
- March 23, 2026
38th Turkish National Congress for Nuclear Medicine
April 1-5, 2026
Antalya, Turkey
Siemens Booth -
JFMN 2026
- February 16, 2026
12th Annual Congress of JFMN (Journées Francophones de Médecine Nucléaire)
March 19-21, 2026
Montrouge, France
Booth #6.11 -
[Article] Evaluation of ThinkQA (v2.0.1.11) as an online secondary dose check for MR guided radiation therapy with the Elekta Unity MR-Linac
- February 16, 2026
Ariadne S. Brodmann, John A. Baines
Physical and Engineering Sciences in Medicine | https://doi.org/10.1007/s13246-025-01693-0 -
DOSIsoft opens a New Office in Montpellier
- February 16, 2026
We are pleased to announce that DOSIsoft opened a new office within ICM – Institut du Cancer de Montpellier in Montpellier, France Being located directly at ICM – Institut du Cancer de Montpellier allows us to further strengthen a long-standing collaboration with the Nuclear Medicine team, while also facilitating research activities with the IRCM –